Tamsulosin Hydrochloride Capsule
Product Images NDC 63187-358

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 63187-358). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-dose Administration Of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted And Fed Conditions (n=8) (Tamsulosin Fig1)

FDA Label Image

Figure 2a Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 1 (Tamsulosin Fig2)

FDA Label Image

Figure 2b Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 2 (Tamsulosin Fig3)

FDA Label Image

Figure 3a Mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Tamsulosin Fig4)

Figure 3a Mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Tamsulosin Fig4)
Figure 3A shows the results of a study, displaying the mean increase in peak urine flow rate measured in L/sec. Three treatment groups were given different doses of medication or a placebo. The study lasted for a variable duration of weeks, with a total of 635, 621, 617, 755, 752, 713, and 694 participants in each respective treatment group.*
FDA Label Image

Figure 3b Mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Tamsulosin Fig5)

Figure 3b Mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Tamsulosin Fig5)
The text describes a figure labeled "Figure 3B" which shows the mean increase in peak urine flow rate measured in mL/Sec for a study labeled "Study 2". The figure includes a graph with the x-axis labeled "Duration of Treatment (weeks)" and the y-axis labeled "Mean Increase in Peak Urine Flow Rate (mL/Sec)". The graph shows a line increasing for 20 weeks of treatment. However, there is some unreadable text in the figure that is not available for evaluation.*
FDA Label Image

63187-358-30 (Tamsulosin Fig6)

63187-358-30 (Tamsulosin Fig6)
This is a description of Tamsulosin HCI 0.4mg, a medication packaged by Proficient Rx LP in Thousand Oaks, CA. The package contains 30 olive green/orange opaque hard gelatin capsules imprinted with L A0 on the cap, and 53 on the body, each filled with white to off-white beadets. Every capsule contains Tamsulosin Hydrochloride USP 0.4mg, and the product has a lot number of 00000 and an expiration date of 00/00/00. The medication is distributed by Rising Health, LLC, Saddle Brook, NJ, and manufactured in India. It should be stored at 20°-25°C (68°77°F) and kept out of the reach of children.*
FDA Label Image

Chemical Structure (Tamsulosin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.